Great Bay Bio 大湾生物
Great Bay Bio (GBB), headquartered in Hong Kong Science Park, is a biotech company leveraging AI, big data mining, and automation to revolutionize drug development. The company offers AI-enabled platforms such as AlfaCell for site-specific integration cell line development, AlfaMedX for cell culture media development, and AlfaOPA for no-screening cell culture media optimization. GBB operates a 3,000㎡ R&D laboratory and CMC platform supporting clinical trial approvals in China and the US. With nearly 100 patents and multiple commercialized AI technology platforms, GBB has established partnerships with leading domestic and international enterprises. The company has received ISO 9001:2015 certification, numerous innovation awards, and was selected for Forbes Asia 100 to Watch 2024, positioning it as a leading innovator in biopharmaceutical development in the Greater Bay Area.
Great Bay Bio 大湾生物
Great Bay Bio (GBB), headquartered in Hong Kong Science Park, is a biotech company leveraging AI, big data mining, and automation to revolutionize drug development. The company offers AI-enabled platforms such as AlfaCell for site-specific integration cell line development, AlfaMedX for cell culture media development, and AlfaOPA for no-screening cell culture media optimization. GBB operates a 3,000㎡ R&D laboratory and CMC platform supporting clinical trial approvals in China and the US. With nearly 100 patents and multiple commercialized AI technology platforms, GBB has established partnerships with leading domestic and international enterprises. The company has received ISO 9001:2015 certification, numerous innovation awards, and was selected for Forbes Asia 100 to Watch 2024, positioning it as a leading innovator in biopharmaceutical development in the Greater Bay Area.